메뉴 건너뛰기




Volumn 29, Issue 4, 2002, Pages 486-493

Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: An extended pilot study

Author keywords

Gliomas; Local injection; Peptidic receptor targeting; Yttrium 90 labelled octreotide

Indexed keywords

FLUORODEOXYGLUCOSE F 18; OCTREOTIDE[DEXTRO 1 PHENYLALANINE 3 TYROSINE 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID] Y 90; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DOTATOC YTTRIUM 90; YTTRIUM 90; (DOTA(0) PHE(1) TYR(3))OCTREOTIDE; (DOTA(0)-PHE(1)-TYR(3))OCTREOTIDE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; OCTREOTIDE; SOMATOSTATIN RECEPTOR; YTTRIUM;

EID: 0036546961     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-001-0717-x     Document Type: Article
Times cited : (80)

References (25)
  • 14
    • 0034669697 scopus 로고    scopus 로고
    • Phase I trial results of iodine-131-labelled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
    • (2000) J Clin Oncol , vol.18 , pp. 3862-3872
    • Cokgor, I.1    Akabani, G.2    Kuan, C.T.3
  • 20
    • 0033033382 scopus 로고    scopus 로고
    • Radiometal-labelled macrocyclic chelator-derivatised somatostatin analogue with superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy
    • (1999) Chem Eur J , vol.5 , pp. 1974-1981
    • Heppeler, A.1    Froidevaux, S.2    Maecke, H.R.3
  • 22
    • 0008697184 scopus 로고
    • New York: Society of Nuclear Medicine
    • (1985) MIRD Pamphlet , vol.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.